Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

AstraZeneca88 enrolled

Overview

AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.

Study Type

OBSERVATIONAL

Enrollment

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * All patients who has experienced cardiovascular events Exclusion Criteria: * Patients with no cardiovascular events.

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.